If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
152.90    3.40 (2.27%)
Bid:
147.50
Ask:
152.90
Spread: 5.40 (3.661%)
Market Cap: £378.07m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Holding(s) in Company

12 Jul 2007 14:34

Marshalls PLC12 July 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlyingissuer of existing shares to which votingrights are attached: Marshalls plc 2. Reason for the notification(please tick the appropriate box or boxes) An acquisition or disposal of voting rights X An acquisition or disposal of financial instrumentswhich may result in the acquisition of shares alreadyissued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the AXA S.A. and its groupnotification obligation: of companies 4. Full name of shareholder(s) (if different from 3): See 9. 5. Date of the transaction (and date on which the 10 July 2007threshold is crossed or reached if different): 6. Date on which issuer notified: 12 July 2007 7. Threshold(s) that is/are crossed or reached: 7% 8. Notified details: A: Voting rights attached to shares Class/ Situation Resulting situation aftertype of previous to the the triggering transactionshares triggering transaction Number of Number Number of Number of % of voting shares of voting shares voting rights rights rights Direct Direct Indirect Direct IndirectGB00B012BV22 10,527,880 10,527,880 9,766,880 9,766,880 461,000 6.82 0.32 B: Financial Instruments Resulting situation after the triggering transaction Type of Expiration Exercise/ Number of voting rights that may % offinancial date Conversion be acquired if the instrument is votinginstrument Period/ Date exercised/ converted rights N/A N/A N/A N/A N/A Total (A+B)Number of voting rights % of voting rights10,227,880 7.15% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Name of the Company/ Number of shares % of issuedFund share capital AXA Sun Life plc 972,515 0.67958Sun Life Unit Assurance Ltd a/c X 900,000 0.62890Sun Life Unit Assurance Ltd a/c X 1,096,371 0.76612AXA UK Investment Co ICVC 400,000 0.27951Distribution FundAXA UK Investment Co ICVC 35,000 0.02446Extra Income FundPPP Healthcare Group 130,000 0.09084Sun Life Pensions Management 99,273 0.06937Sun Life Assurance Society plc 431,800 0.30173AXA Insurance UK 512,000 0.35778AXA UK Group Pension Scheme 26,000 0.01817Sun Life International (IOM) Ltd 1,300,000 0.90842Sun Life Pensions Management Ltd 111,119 0.07765Sun Life Unit Assurance Ltd 40,000 0.02795LTAV UK EquitySun Life Unit Assurance Ltd 25,430 0.01777FTSE All Share TrackerSun Life Pensions Management 160,000 0.11181LTAV UK EquitySun Life Pensions Management 127,001 0.08875FTSE All Share TrackerAXA Winterthur 35,973 0.02514ASL With Profit Transition Fund 1,869,489 1.30636SLAS With Profit Transition 1,955,909 1.36675 Proxy Voting:10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: 14. Contact name: Elizabeth Blease, Company Secretary, Marshalls plc 15. Contact telephonenumber: 01484 438900 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jul 20264:40 pmRNSDirector/PDMR Shareholding
3rd Jul 20267:00 amRNSDirector Declaration
16th Jun 20269:23 amRNSDirector/PDMR Shareholding
16th Jun 20269:20 amRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSHolding(s) in Company
29th May 202612:17 pmRNSHolding(s) in Company
22nd May 20264:01 pmRNSDirector/PDMR Shareholding
22nd May 20263:58 pmRNSDirector/PDMR Shareholding
15th May 202611:04 amRNSDirector/PDMR Shareholding
15th May 202611:03 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
14th May 202610:05 amRNSDirector/PDMR Shareholding
13th May 20263:08 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Trading Update
15th Apr 202612:17 pmRNSDirector/PDMR Shareholding
15th Apr 202612:15 pmRNSDirector/PDMR Shareholding
17th Mar 20263:01 pmRNSDirector/PDMR Shareholding
17th Mar 20262:59 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSFinal Results
16th Mar 20267:00 amRNSFinal Results
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:27 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
11th Mar 20264:18 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNS-RNotice of Engage Investor Presentation
13th Feb 20263:21 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
13th Feb 20263:04 pmRNSDirector/PDMR Shareholding
19th Jan 20267:01 amRNSTrading Statement
19th Jan 20267:00 amRNSDirectorate change
9th Jan 202612:40 pmRNSDirector/PDMR Shareholding
9th Jan 202612:38 pmRNSDirector/PDMR Shareholding
6th Jan 20269:36 amRNSNotice of Trading Update
9th Dec 20253:21 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSBoard changes
12th Nov 20257:00 amRNSTrading Update
10th Nov 202510:30 amRNSDirector/PDMR Shareholding
10th Nov 202510:29 amRNSDirector/PDMR Shareholding
10th Nov 202510:27 amRNSDirector/PDMR Shareholding
30th Oct 20259:01 amRNSNotice of Trading Update
9th Oct 202512:45 pmRNSDirector/PDMR Shareholding
9th Oct 202512:44 pmRNSDirector/PDMR Shareholding
9th Oct 202512:42 pmRNSDirector/PDMR Shareholding
10th Sep 202512:06 pmRNSDirector/PDMR Shareholding
10th Sep 202512:05 pmRNSDirector/PDMR Shareholding
10th Sep 202512:04 pmRNSDirector/PDMR Shareholding
12th Aug 20259:28 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.